43rd National Immunization Conference (NIC): Update on Pneumococcal Vaccines

Presenters in this workshop will discuss the revised ACIP recommendations for use of 23-valent pneumococcal polysaccharide vaccine in high-risk adults and children, and the potential impact on invasive pneumococcal disease of a future 13-valent vaccine.